Patents Assigned to Centre National de al Recherche Scientifique (CNRS)
  • COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS
    Publication number: 20130165523
    Abstract: The present invention concerns a method for treating and/or preventing a disease in a subject comprising the step of administrating an effective amount of a compound of formula I to a subject in need thereof.
    Type: Application
    Filed: November 5, 2012
    Publication date: June 27, 2013
    Applicants: Universite Montpellier 2 Sciences Et Techniques, Centre National De Al Recherche Scientifique (CNRS)
    Inventors: Centre National De Al Recherche Scientifique (CN, Universite Montpellier 2 Sciences Et Techniques
  • Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
    Patent number: 6319931
    Abstract: The present invention relates in particular to a combination product comprising at least one compound with affinity for the mitochondrial benzodiazepine receptor, and to at least one apoptosis-inducing agent for simultaneous or separate use or for use spread out over time, which is intended for the treatment of cancer. Another aspect of the present invention relates to the use of the said compound and/or of the said combination product for the manufacture of a medicinal product intended to facilitate the induction of apoptosis.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: November 20, 2001
    Assignee: Centre National de al Recherche Scientifique (CNRS)
    Inventors: Guido Kroemer, Tamara Hirsch, Didier Decaudin